Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect <scp> HbA <sub>1c</sub> </scp> reliability
Switching to fructosamine or GA is unlikely to improve the accuracy of laboratory glycaemic monitoring beyond that of HbA<sub>1c</sub> in a population with high prevalence of conditions reported to affect HbA<sub>1c</sub> reliability.
Authors
- Anxious J. Niwaha (ORCID: https://orcid.org/0000-0003-0939-9380)
- Priscilla Balungi
- Angus G. Jones (ORCID: https://orcid.org/0000-0002-0883-7599)
- Moffat Nyirenda (ORCID: https://orcid.org/0000-0003-2120-4806)
- Andrew Tym Hattersley (ORCID: https://orcid.org/0000-0001-5620-473X)
- Timothy J. McDonald (ORCID: https://orcid.org/0000-0003-3559-6660)
- Beverley M. Shields
Institutions
- University of Exeter (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Uganda Virus Research Institute (UG)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1111/dme.70011
- Citations
- 1
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- NIHR Exeter Clinical Research Facility